MolOrgGPT: <i>De Novo</i> Generation via Large Language Models and Reinforcement Learning

We present a general framework for the <i>de novo</i> design of small molecules with desirable chemical properties, developed to aid the creation of novel chemical entities with potential therapeutic use. The system is built upon a foundational Large Language Model trained on a large comprehensive chemical database capable of generating structurally diverse and synthetically accessible compounds. It is then fine-tuned through reinforcement learning to enhance its capacity to generate molecules tailored to specific biological targets. As a case study, we apply this framework to design molecules targeting key proteins involved in Alzheimer's disease. The generated compounds underwent molecular docking studies to assess their binding affinities and prioritize candidates with optimal predicted interactions. The top-ranked molecules were further analyzed based on their binding modes and key molecular interactions with the target proteins. The results suggest that our generative model produces viable, drug-like molecules with favorable interactions, underscoring its potential as a valuable tool in early stage drug discovery.

Authors

Institutions

Publication Details

Journal
Journal of Chemical Information and Modeling
Published
2026-01-07
DOI
https://doi.org/10.1021/acs.jcim.5c02400
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MolOrgGPT: De Novo Generation via Large Language Models and Reinforcement Learning

Nuria Eugenia Campillo, Guillermo Marcos-Ayuso, Oscar Toledano, Pablo Varas Pardo et al.
Journal of Chemical Information and Modeling
Computational Drug Discovery Methods
article

MolOrgGPT: De Novo Generation via Large Language Models and Reinforcement Learning

Nuria Eugenia Campillo, Guillermo Marcos-Ayuso, Oscar Toledano, Pablo Varas Pardo, David Quesada
article en

Abstract

We present a general framework for the <i>de novo</i> design of small molecules with desirable chemical properties, developed to aid the creation of novel chemical entities with potential therapeutic use. The system is built upon a foundational Large Language Model trained on a large comprehensive chemical database capable of generating structurally diverse and synthetically accessible compounds. It is then fine-tuned through reinforcement learning to enhance its capacity to generate molecules tailored to specific biological targets. As a case study, we apply this framework to design molecules targeting key proteins involved in Alzheimer's disease. The generated compounds underwent molecular docking studies to assess their binding affinities and prioritize candidates with optimal predicted interactions. The top-ranked molecules were further analyzed based on their binding modes and key molecular interactions with the target proteins. The results suggest that our generative model produces viable, drug-like molecules with favorable interactions, underscoring its potential as a valuable tool in early stage drug discovery.

Journal of Chemical Information and ModelingVol. 66(2)
Biotech Park (IN), Centro de Investigaciones Biológicas Margarita Salas (ES), Institute of Mathematical Sciences (ES), Universidad Autónoma de Madrid (ES)
Openalex Percentile: Top 93%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.